Vedolizumab Reduces Postoperative Crohn’s Disease Recurrence
Vedolizumab prevented the postoperative recurrence of Crohn’s disease and should be considered a prophylactic treatment in patients with at least one risk factor for recurrence.
Medscape Medical News
source https://www.medscape.com/viewarticle/vedolizumab-reduces-postoperative-crohns-disease-recurrence-2024a1000p7b?src=rss
Medscape Medical News
source https://www.medscape.com/viewarticle/vedolizumab-reduces-postoperative-crohns-disease-recurrence-2024a1000p7b?src=rss
Comments
Post a Comment